The global need for effective antibiotics-A summary of plenary presentations

被引:40
作者
Alvan, Gunnar [1 ]
Edlund, Charlotta [2 ]
Heddini, Andreas [1 ]
机构
[1] Uppsala Univ, SE-75105 Uppsala, Sweden
[2] Med Prod Agcy, SE-75103 Uppsala, Sweden
关键词
Drug resistance; Microbial; Anti-Bacterial agents; Communicable disease; Emerging; Surveillance; Poverty; Delivery of health care; Drug discovery; Drug regulations; Globalization;
D O I
10.1016/j.drup.2011.01.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To highlight the global need for effective antibiotics and explore possible concerted actions for change, cross-cutting plenary sessions served to frame the program of the conference. These sessions contained presentations on the present state of antibacterial resistance and the availability, the use and misuse of antibiotics. A number of possible actions were discussed, such as rational use of and access to antibiotics from various perspectives. The roles of vaccines and diagnostics were touched upon and followed by in depth discussions on supply-side bottlenecks with their scientific, regulatory and financial challenges. The value chain for research and development (R&D) of antibiotics has to be reengineered if we are to realize the development of much needed new antibiotics. This challenge will require a multitude of actions, some of which are related to changing the financial realities of antibiotics and interventions by global and regional institutions. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:70 / 76
页数:7
相关论文
共 10 条
[1]  
[Anonymous], 2009, EMEA5761762009 ECDC
[2]   The role of the pharmaceutical industry in meeting the public health threat of antibacterial resistance [J].
Bergstrom, Richard .
DRUG RESISTANCE UPDATES, 2011, 14 (02) :77-78
[3]  
Council of the European Union, 2009, COUNC CONCL INN INC
[4]   Fighting bacterial infections-Future treatment options [J].
Fernebro, Jenny .
DRUG RESISTANCE UPDATES, 2011, 14 (02) :125-139
[5]   1ST CLINICAL USE OF PENICILLIN [J].
FLETCHER, C .
BRITISH MEDICAL JOURNAL, 1984, 289 (6460) :1721-1723
[6]   Rene Dubos: A harbinger of microbial resistance to antibiotics [J].
Moberg, CL .
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1996, 2 (03) :287-297
[7]  
Moran M., 2005, NEW LANDSCAPE NEGLEC
[8]  
Morel Chantal M, 2010, BMJ, V340, pc2115, DOI 10.1136/bmj.c2115
[9]   Conserving antibiotics for the future: New ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective [J].
Mouton, Johan W. ;
Ambrose, Paul G. ;
Canton, Rafael ;
Drusano, George L. ;
Harbarth, Stephan ;
MacGowan, Alasdair ;
Theuretzbacher, Ursula ;
Turnidge, John .
DRUG RESISTANCE UPDATES, 2011, 14 (02) :107-117
[10]  
*SWED GOV, 2009, REP C INN INC EFF AN